Vertebral artery dissection in a patient with migraine treated with calcitonin gene-related peptide monoclonal antibody: a case report and FAERS database analysis
Abstract Background Migraine is associated with cervical artery dissection (CeAD). Calcitonin gene-related peptide (CGRP) is a multifunctional neuropeptide with vasodilatory effects. The use of anti-CGRP monoclonal antibodies (CGRP mAb) may affect cerebrovascular disease risk; however, no reports ha...
Saved in:
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-01-01
|
| Series: | BMC Neurology |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12883-024-04009-z |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832571603510099968 |
|---|---|
| author | Daiki Tokuyasu Shungo Imai Shih-Pin Chen Keiko Ihara Narumi Watanabe Yoshikane Izawa Jin Nakahara Satoko Hori Tsubasa Takizawa |
| author_facet | Daiki Tokuyasu Shungo Imai Shih-Pin Chen Keiko Ihara Narumi Watanabe Yoshikane Izawa Jin Nakahara Satoko Hori Tsubasa Takizawa |
| author_sort | Daiki Tokuyasu |
| collection | DOAJ |
| description | Abstract Background Migraine is associated with cervical artery dissection (CeAD). Calcitonin gene-related peptide (CGRP) is a multifunctional neuropeptide with vasodilatory effects. The use of anti-CGRP monoclonal antibodies (CGRP mAb) may affect cerebrovascular disease risk; however, no reports have associated CGRP mAb with CeAD. Case presentation and FAERS database analysis We report a case of vertebral artery dissection in a 39-year-old woman with migraine treated with galcanezumab. We searched the number of cases where cerebral and cervical artery dissection were reported as adverse effects of CGRP mAb using the FDA Adverse Event Reporting System (FAERS) database. Six and ten such cases were reported regarding galcanezumab and CGRP mAbs use, respectively. The reporting odds ratios for galcanezumab and CGRP mAbs were elevated. Conclusion Although migraine is reported to be associated with CeAD, the use of CGRP mAb might be related to CeAD and warrant further investigation. |
| format | Article |
| id | doaj-art-99df3ee635fe428693b86e83125b67ea |
| institution | Kabale University |
| issn | 1471-2377 |
| language | English |
| publishDate | 2025-01-01 |
| publisher | BMC |
| record_format | Article |
| series | BMC Neurology |
| spelling | doaj-art-99df3ee635fe428693b86e83125b67ea2025-02-02T12:30:10ZengBMCBMC Neurology1471-23772025-01-012511510.1186/s12883-024-04009-zVertebral artery dissection in a patient with migraine treated with calcitonin gene-related peptide monoclonal antibody: a case report and FAERS database analysisDaiki Tokuyasu0Shungo Imai1Shih-Pin Chen2Keiko Ihara3Narumi Watanabe4Yoshikane Izawa5Jin Nakahara6Satoko Hori7Tsubasa Takizawa8Department of Neurology, Keio University School of MedicineDivision of Drug Informatics, Keio University Faculty of PharmacyDepartment of Neurology, Keio University School of MedicineDepartment of Neurology, Keio University School of MedicineDepartment of Neurology, Keio University School of MedicineDepartment of Neurology, Keio University School of MedicineDepartment of Neurology, Keio University School of MedicineDivision of Drug Informatics, Keio University Faculty of PharmacyDepartment of Neurology, Keio University School of MedicineAbstract Background Migraine is associated with cervical artery dissection (CeAD). Calcitonin gene-related peptide (CGRP) is a multifunctional neuropeptide with vasodilatory effects. The use of anti-CGRP monoclonal antibodies (CGRP mAb) may affect cerebrovascular disease risk; however, no reports have associated CGRP mAb with CeAD. Case presentation and FAERS database analysis We report a case of vertebral artery dissection in a 39-year-old woman with migraine treated with galcanezumab. We searched the number of cases where cerebral and cervical artery dissection were reported as adverse effects of CGRP mAb using the FDA Adverse Event Reporting System (FAERS) database. Six and ten such cases were reported regarding galcanezumab and CGRP mAbs use, respectively. The reporting odds ratios for galcanezumab and CGRP mAbs were elevated. Conclusion Although migraine is reported to be associated with CeAD, the use of CGRP mAb might be related to CeAD and warrant further investigation.https://doi.org/10.1186/s12883-024-04009-zMigraineCervical artery dissectionVertebral artery dissectionCGRPGalcanezumabCase report |
| spellingShingle | Daiki Tokuyasu Shungo Imai Shih-Pin Chen Keiko Ihara Narumi Watanabe Yoshikane Izawa Jin Nakahara Satoko Hori Tsubasa Takizawa Vertebral artery dissection in a patient with migraine treated with calcitonin gene-related peptide monoclonal antibody: a case report and FAERS database analysis BMC Neurology Migraine Cervical artery dissection Vertebral artery dissection CGRP Galcanezumab Case report |
| title | Vertebral artery dissection in a patient with migraine treated with calcitonin gene-related peptide monoclonal antibody: a case report and FAERS database analysis |
| title_full | Vertebral artery dissection in a patient with migraine treated with calcitonin gene-related peptide monoclonal antibody: a case report and FAERS database analysis |
| title_fullStr | Vertebral artery dissection in a patient with migraine treated with calcitonin gene-related peptide monoclonal antibody: a case report and FAERS database analysis |
| title_full_unstemmed | Vertebral artery dissection in a patient with migraine treated with calcitonin gene-related peptide monoclonal antibody: a case report and FAERS database analysis |
| title_short | Vertebral artery dissection in a patient with migraine treated with calcitonin gene-related peptide monoclonal antibody: a case report and FAERS database analysis |
| title_sort | vertebral artery dissection in a patient with migraine treated with calcitonin gene related peptide monoclonal antibody a case report and faers database analysis |
| topic | Migraine Cervical artery dissection Vertebral artery dissection CGRP Galcanezumab Case report |
| url | https://doi.org/10.1186/s12883-024-04009-z |
| work_keys_str_mv | AT daikitokuyasu vertebralarterydissectioninapatientwithmigrainetreatedwithcalcitoningenerelatedpeptidemonoclonalantibodyacasereportandfaersdatabaseanalysis AT shungoimai vertebralarterydissectioninapatientwithmigrainetreatedwithcalcitoningenerelatedpeptidemonoclonalantibodyacasereportandfaersdatabaseanalysis AT shihpinchen vertebralarterydissectioninapatientwithmigrainetreatedwithcalcitoningenerelatedpeptidemonoclonalantibodyacasereportandfaersdatabaseanalysis AT keikoihara vertebralarterydissectioninapatientwithmigrainetreatedwithcalcitoningenerelatedpeptidemonoclonalantibodyacasereportandfaersdatabaseanalysis AT narumiwatanabe vertebralarterydissectioninapatientwithmigrainetreatedwithcalcitoningenerelatedpeptidemonoclonalantibodyacasereportandfaersdatabaseanalysis AT yoshikaneizawa vertebralarterydissectioninapatientwithmigrainetreatedwithcalcitoningenerelatedpeptidemonoclonalantibodyacasereportandfaersdatabaseanalysis AT jinnakahara vertebralarterydissectioninapatientwithmigrainetreatedwithcalcitoningenerelatedpeptidemonoclonalantibodyacasereportandfaersdatabaseanalysis AT satokohori vertebralarterydissectioninapatientwithmigrainetreatedwithcalcitoningenerelatedpeptidemonoclonalantibodyacasereportandfaersdatabaseanalysis AT tsubasatakizawa vertebralarterydissectioninapatientwithmigrainetreatedwithcalcitoningenerelatedpeptidemonoclonalantibodyacasereportandfaersdatabaseanalysis |